Streetbeat News

Price Targets

TVTX

HC Wainwright & Co. analyst Ed Arce has reaffirmed a Buy rating on Travere Therapeutics (NASDAQ:TVTX) and increased the price target from $18 to $20.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 6:40 pm

VRCA

Jefferies analyst Glen Santangelo has reiterated a Buy rating on Verrica Pharmaceuticals (NASDAQ:VRCA) and maintained a price target of $10. This endorsement from a reputable analyst could influence investor sentiment and potentially impact VRCA's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 6:37 pm

PFE

Pfizer, Inc. (NYSE:PFE) shares are trading higher on Friday after the company announced an increase in its quarterly cash dividend from 41 cents to 42 cents per share, payable on March 1 to stockholders of record as of January 26. Despite the uptick, the stock is still down over 11% in the past five days and over 47% year-to-date. Pfizer also completed its acquisition of Seagen for approximately $43 billion. Analysts from Barclays, UBS, and Truist Securities have lowered their price targets on Pfizer this week. The stock is currently trading above its 50-day moving average but well below its 52-week high.

Portfolio Pulse from Erica Kollmann

December 15, 2023 | 6:31 pm

ALNY

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating on Alnylam Pharmaceuticals (NASDAQ:ALNY) and maintained a price target of $395.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 6:31 pm

ORLA

RBC Capital analyst Michael Siperco has initiated coverage on Orla Mining with an Outperform rating and set a price target of C$6. Orla Mining is listed on the Toronto Stock Exchange under the symbol OLA.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 6:26 pm

GBTG

Citigroup analyst Peter Christiansen has upgraded Global Business Travel (GBTG) from Neutral to Buy and increased the price target from $7.5 to $8. The upgrade suggests a positive outlook on GBTG's stock performance.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 6:14 pm

ALL

BMO Capital analyst Michael Zaremski has maintained a 'Market Perform' rating on Allstate (NYSE:ALL) and increased the price target from $125 to $140. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 6:08 pm

BA

Boeing's stock (BA) is trading higher following UBS's decision to maintain a Buy rating and increase the price target from $275 to $315. This endorsement from UBS suggests confidence in Boeing's future performance and may influence investor sentiment positively.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 6:07 pm

COST

BMO Capital analyst Kelly Bania has maintained an Outperform rating on Costco Wholesale (NASDAQ:COST) and increased the price target from $612 to $700.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 6:07 pm

SHIBUSD

Shiba Inu (CRYPTO: SHIB), a decentralized meme token, has been experiencing a bullish trend with a 14% increase over the past month. Currently ranked 16th by market cap, SHIB's price is at $0.00000971. Changelly predicts a short-term increase to $0.00001072 by Dec. 16, 2023, and substantial long-term growth, with a potential peak at $0.0001609839 by 2030. Despite the optimism, investors are reminded of the crypto market's volatility and the need for thorough research.

Portfolio Pulse from Murtuza Merchant

December 15, 2023 | 6:05 pm